<DOC>
	<DOCNO>NCT01929291</DOCNO>
	<brief_summary>The purpose study collect safety information pre-adolescents , adolescent adult Boostrix vaccination administer accord approve prescribe information Korea .</brief_summary>
	<brief_title>Post-marketing Surveillance Assess Safety Boostrix Vaccine Given According Prescribing Information Korea</brief_title>
	<detailed_description>Protocol amendment 3 rationale follow : - Age analysis set specify . - Subjects pregnancy analyze pregnancy status before/after vaccination . - Pregnancy notification must do within 2 week</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written sign inform consent obtain subject/ subject 's parent ( ) /Legally Acceptable Representative ( ) child . Korean male female subject recently vaccinate eligible receive Boostrix accord locally approve Prescribing Information . Those eligible vaccination accord local Prescribing Information . Child care .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Korea</keyword>
	<keyword>Post-marketing surveillance</keyword>
	<keyword>Boostrix</keyword>
	<keyword>Prescribing information</keyword>
	<keyword>Safety</keyword>
</DOC>